9013 RESULTS
COMMENT Peter was both a great scientist and a consummate gentleman. His generosity sharing reagents is testimony to his selflessness. He will be sorely missed. gsb4g 0 ...
COMMENT This study provides new information about a molecular pathogenic mechanism that linked innate immunity activation to increased Aβ production by an interferon-induced transmembrane protein that upregulates γ-secretase activity. Seeing the genetic evidence ...
COMMENT No words can describe how sorry I feel for the loss of Dr. Peter Davies—a true legend and leader in the area of tau biology, in general, and tau pathology relevant to Alzheimer's disease and related tauopathies. His friendly and collaborative nature ...
COMMENT I was deeply saddened upon hearing of the passing of Peter Davies. Peter's pioneering work contributed greatly to our understanding of the roles that the cholinergic system and tau play in the pathogenesis of the Alzheimer's disease (AD). ...
COMMENT I’m deeply saddened to hear about Peter Davies’ demise. He had a profound influence on my early career. He was one of three speakers at a satellite preconference meeting at the first SFN I attended, in Dallas. I believe that was 1985—my initial entrée ...
COMMENT I am also very saddened to learn of Peter Davies' passing. I first met him in the middle 1980s, when I invited him to chair Alzheimer's disease grant application review panels for the NIA/NIH. His sense of humor and good spirits always made the ...
COMMENT We were shocked by the news of the untimely death of Peter Davies, and we second all the thoughtful and warm remarks made by colleagues about the remarkable person he was. We met Peter on numerous occasions at SfN or Alzheimer meetings. In the late 1980s ...
COMMENT I was greatly saddened to hear of Peter’s passing. He was a Goliath in the Alzheimer’s field, and he leaves an enduring legacy. I deeply admired and respected his science and personality. Although he might be considered dogmatic, I always found him to be ...
COMMENT Like many others in our field, I was greatly saddened by the news that Peter Davies had died. I came to know Peter in the mid-1970s, when he led one of three research teams in the United Kingdom that first defined the cholinergic deficit which occurs so ...
COMMENT I was extremely saddened to read that Peter Davies died recently. His pivotal and pioneering study published in Lancet with A.J. Maloney indicated the importance of cholinergic hypofunction in Alzheimer’s disease and provided the rationale for the ...
COMMENT I have known Dr. Peter Davies for more than 30 years. I first met him in 1986 at a Bunbury Symposium on the Molecular Neuropathology of Aging that he organized at Cold Spring Harbor Laboratories. Peter made significant and lasting contributions to the ...
COMMENT I was saddened to hear that the world of AD, and all of us who knew Peter, had lost him. His early discoveries regarding the cholinergic system were highly influential in leading to the development of cholinergic therapies. His work and these drugs ...
COMMENT Peter was an enormously kind man, generous with his time and resources. He influenced our work by creating terrific monoclonal antibodies against tau, which he shared willingly and repeatedly. These reagents were essential to a number of our published ...
COMMENT My colleagues and I express sincere condolences to the family of the late Peter Davies. His passing is such a big loss to the research community. I have had several opportunities to communicate with Peter via telephone and email, although I did not have a ...
COMMENT The publication by Peter Davies and A.J. Maloney in The Lancet (1976) describing the selective loss of central cholinergic neurons in autopsy-verified cases of Alzheimer’s disease provided much of the scientific motivation to test the effects of ...
